PolyPeptide specializes in developing small-scale to large-scale peptide production processes. Whether our customers require gram or multi-kilogram quantities, we can support a custom or generic project at every development step and every quantity requirement, even with the most complex peptides.
Our Core Values
INNOVATION - We are curious and explore new ways. - We are also ambitious and find solutions.
EXCELLENCE - We have a strong technical knowledge, and we deliver results - We lead quality in everything we do - We are adaptable and customer focused
TRUST - We believe in teamwork and collaboration. - We lead by example and accept responsibility - We are transparent and we show integrity.
PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India with around 1,200 employees as per the middle of 2022. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.